Literature DB >> 11707846

Staging and monitoring response to treatment in primary non-Hodgkin's lymphoma of bone marrow using (18)F-fluorodeoxyglucose positron emission tomography.

A Matthies1, S J Schuster, A Alavi.   

Abstract

Bone marrow involvement can be found in patients with low-, intermediate-, or high-grade non-Hodgkin's lymphoma. A 40-year-old woman experienced onset of low back pain radiating into her entire right lower extremity. Plain x-rays of her right leg and computed tomography of chest, abdomen, and pelvis were unremarkable. Magnetic resonance imaging of pelvis and thighs revealed diffusely abnormal marrow signal (low T1 and high T2 weighted) in the pelvis and femora. The patient underwent (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) scan to evaluate the extent of her disease. The scan revealed diffuse scattered foci of abnormal FDG uptake in the bone/bone marrow, which was particularly intense in the axial bones. Bone marrow biopsy confirmed extensive involvement of the bone marrow with diffuse large B-cell lymphoma. This case report highlights the utility of FDG-PET in the detection of bone marrow involvement by aggressive lymphoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11707846     DOI: 10.3816/clm.2001.n.006

Source DB:  PubMed          Journal:  Clin Lymphoma        ISSN: 1526-9655


  3 in total

1.  Effect of colony-stimulating factor and conventional- or high-dose chemotherapy on FDG uptake in bone marrow.

Authors:  Toshiki Kazama; Nancy Swanston; Donald A Podoloff; Homer A Macapinlac
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-08-31       Impact factor: 9.236

2.  Primary diffuse large B-cell lymphoma of the bone marrow in a frail and elderly patient successfully treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone.

Authors:  Pasquale Niscola; Massimiliano Palombi; Stefano Fratoni; Alessio Perrotti; Paolo de Fabritiis
Journal:  Blood Res       Date:  2013-12-24

3.  Clinical features and prognostic factors of primary bone marrow lymphoma.

Authors:  Gangjian Wang; Yu Chang; Xiaolong Wu; Xin Li; Ling Li; Lei Zhang; Xiaorui Fu; Zhenchang Sun; Xudong Zhang; Mingzh Zhang
Journal:  Cancer Manag Res       Date:  2019-03-29       Impact factor: 3.989

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.